BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 497547)

  • 1. Inhibitory presynaptic effects of hydralazine on noradrenergic nerve terminals of the rat tail artery [proceedings].
    Chevillard C; Da Ponte F; Mathieu MN; Saïag B; Worcel M
    Br J Pharmacol; 1979 Nov; 67(3):418P-419P. PubMed ID: 497547
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine.
    Dumont O; Pinaud F; Guihot AL; Baufreton C; Loufrani L; Henrion D
    Cardiovasc Res; 2008 Feb; 77(3):600-8. PubMed ID: 18006444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydralazine on regional blood flow in conscious dogs.
    Chelly JE; Doursout MF; Begaud B; Tsao CC; Hartley CJ
    J Pharmacol Exp Ther; 1986 Aug; 238(2):665-9. PubMed ID: 3735136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in purinergic signalling in developing and ageing rat tail artery: importance for temperature control.
    Wallace A; Knight GE; Cowen T; Burnstock G
    Neuropharmacology; 2006 Feb; 50(2):191-208. PubMed ID: 16226282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 4-aminopyridine on the adrenergic nerve terminals of rabbit arteries.
    Ikushima S; Muramatsu I; Fujiwara M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):792-7. PubMed ID: 7299697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of hydralazine on adrenal and cardiac sympathetic nerve activity in anesthetized rats.
    Yoshioka M; Togashi H; Minami M; Saito H
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):313-20. PubMed ID: 3797810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and postjunctional actions of hydralazine in vascular and nonvascular smooth muscle in vitro.
    Brown NL; Chevillard C; Worcel M
    J Pharmacol Exp Ther; 1983 Aug; 226(2):512-8. PubMed ID: 6875861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic regulation of the release of catecholamines.
    Langer SZ
    Pharmacol Rev; 1980 Dec; 32(4):337-62. PubMed ID: 6267618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological effects of acute and chronic clenbuterol treatments after lesions of central noradrenergic nerve terminals.
    Francès H; Struck I; Simon P; Raisman R
    J Pharmacol; 1986; 17(4):547-52. PubMed ID: 3560967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of released norepinephrine in rat tail artery by neuronal uptake [proceedings].
    Vanhoutte PM; Webb C
    Br J Pharmacol; 1979 May; 66(1):116P. PubMed ID: 454911
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings.
    Pittaluga A; Feligioni M; Longordo F; Arvigo M; Raiteri M
    J Pharmacol Exp Ther; 2005 Apr; 313(1):242-9. PubMed ID: 15608072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus.
    Galzin AM; Moret C; Langer SZ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):725-32. PubMed ID: 6323679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in norepinephrine content of sympathetic neuroeffector organs by alpha adrenergic antagonists and nerve stimulation: evidence for presynaptic control of sympathetic transmitter release in intact animal.
    Wakade AR; Wakade TD
    J Pharmacol Exp Ther; 1984 Feb; 228(2):287-92. PubMed ID: 6141280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced sympathetic noradrenergic neurotransmission in the tail artery of Donryu rats fed with high cholesterol-supplemented diet.
    Karoon P; Burnstock G
    Br J Pharmacol; 1998 Mar; 123(5):1016-21. PubMed ID: 9535033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro differences between human arteries and veins in their responses to hydralazine.
    Lipe S; Moulds RF
    J Pharmacol Exp Ther; 1981 Apr; 217(1):204-8. PubMed ID: 7205655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of neurotransmitters from rat brain nerve terminals after chronic ethanol ingestion: differential effects in cortex and hippocampus.
    Sabriá J; Torres D; Pastó M; Peralba JM; Allali-Hassani A; Parés X
    Addict Biol; 2003 Sep; 8(3):287-94. PubMed ID: 13129830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex.
    Cohen Z; Molinatti G; Hamel E
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):894-904. PubMed ID: 9290587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms.
    Cassis LA; Stitzel RE; Head RJ
    J Pharmacol Exp Ther; 1985 Sep; 234(3):792-803. PubMed ID: 4032290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine has a permissive role on the activation of metabotropic glutamate 5 receptors coexisting with nicotinic receptors on rat hippocampal noradrenergic nerve terminals.
    Parodi M; Patti L; Grilli M; Raiteri M; Marchi M
    Neurochem Int; 2006 Jan; 48(2):138-43. PubMed ID: 16214264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.